Home
Conditions
Central Nervous System Infections

Clinical trial condition

Central Nervous System Infections

Explore clinical trials studying Central Nervous System Infections. Study availability and eligibility vary by location and protocol.

746 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Central Nervous System Infections trial results

Completed

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

NCT01323959

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations: GSK Investigational Site Derval, France

GSK Investigational Site La Chapelle-Basse-Mer, France

GSK Investigational Site La Riche, France

GSK Investigational Site Nantes, France

View all 15 locations

View Trial Details

Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations: GSK Investigational Site Genoa, Liguria, Italy

GSK Investigational Site Milan, Lombardy, Italy

GSK Investigational Site Novara, Piedmont, Italy

GSK Investigational Site Cagliari, Sardinia, Italy

View Trial Details

Completed

Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine

NCT00325143

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
Locations: GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Singapore

View Trial Details

Completed

Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)

NCT00964028

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
Locations: GSK Investigational Site Wuzhou, Guangxi, China

View Trial Details

Completed

Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)

NCT02166346

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +24 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Enhance Wellness for Individuals With Long-Term Physical Disabilities

NCT02815878

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +30 more
Locations: University of Washington Seattle, Washington, United States

View Trial Details

Completed

Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report

NCT02955862

Conditions: Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, Blood-Borne Infections, +25 more
Locations: National hospital for tropical diseases Ham Zong, Vietnam

View Trial Details

Completed

IPV Clinical Trial - The Gambia

NCT01847872

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Medical Research Council Unit Fajara, The Gambia

View Trial Details

Completed

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

NCT00432042

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +53 more
Locations: Alsfeld, Germany

Bad Saulgau, Germany

Bad Säckingen, Germany

Bad Sobernheim, Germany

View all 50 locations

View Trial Details

Completed

Ciprofloxacin for the Prevention of Meningococcal Meningitis

NCT02724046

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: Madarounfa Health District Madarounfa, Maradi Region, Niger

View Trial Details

Central Nervous System Infections

Central Nervous System Infections trial results

Related conditions